MIMargareth Maria Braun Guimarães Imbiriba

Margareth Maria Braun Guimarães Imbiriba

*This is an algorithmically generated author record based on publicly available information.

Margareth Maria Braun Guimarães Imbiriba has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Evaluation of Circulating MicroRNAs in Schizophrenia: From Epigenomic Dysregulation to Potential Biomarkers

    by André Luiz de Souza Rodrigues, Carla de Castro Sant’anna, Diego Di Felipe Ávila Alcantara, Amanda Cohen-Paes, Margareth Maria Braun Guimarães Imbiriba, Rommel Mario Rodriguez Burbano

    To evaluate the expression profile of circulating miRNAs in patients with schizophrenia (hsa-miR-34a, miR-449a, miR-564, miR-432, miR-548d, miR-572, and miR-652) in relation to individual negative controls for the disease. This was an analytical, case-controlled, cross-sectional study, using samples previously collected from patients diagnosed with schizophrenia (N = 650) and a control group (N = 924). Samples were analyzed after RNA extraction and quantification. After making a general comparison between the case and control groups, regardless of gender and other variables, all seven miRNAs showed statistically significant differences (p-value < 0.05). This also occurred in the variables gender, smoking, and alcoholism. Thus, the results indicated that depending on the clinical characteristics in the face of suspected schizophrenia, the miRNAs explored here seem to work as possible biomarkers, as they demonstrated, at various times, important differences between the studied groups.


  • Open Access

    Homocystein, Vitamin B12 and Folic Acid as Screening Biomarkers in Early Diagnosis and Gastric Cancer Monitoring

    by Fernanda Farias de Alcântara, Carla de Castro Sant’anna, Diego Di Felipe Ávila Alcântara, Amanda de Nazaré Cohen-Paes, Paulo Cardoso Soares, Paulo Pimentel de Assumpção, Margareth Maria Braun Guimarães Imbiriba, Rommel Mario Rodriguez Burbano

    Gastric cancer has been demonstrating a reduction in the number of cases over the past decades, largely attributed to advancements in public health practices and increased accessibility to educational initiatives for the general population. Nevertheless, it persists as the third leading cause of mortality globally among both men and women. These fatalities are typically associated with delayed disease detection. The current study assessed the levels of homocysteine, vitamin B12, and folic acid as a means of establishing a screening biomarker profile that could be integrated into routine testing protocols to facilitate swift diagnosis of the illness. A total of 207 control subjects and 207 individuals with gastric cancer were scrutinized, with biochemical measurements conducted using chemiluminescence for homocysteine, folic acid, and vitamin B12. The two groups were matched based on age, tumor location, subtype, tumor classification, presence of Epstein-Barr Virus infection (EBV), and Helicobacter pylori (H. pylori). Significant statistical variances were identified in the mean levels of the triad of substances among cancer patients when compared to the control group for all corresponding variables. In conclusion, our study indicated that analyzing the triad of homocysteine, vitamin B12, and folic acid holds diagnostic value for gastric cancer and could potentially serve as an effective screening marker for this type of cancer in the future.


  • Open Access

    Epidemiological Profile of Ophir Loyola Cancer Hospital: A Snapshot of the Incidence of Solid Neoplasms in the Eastern Amazon

    by Juliana Ramos Chaves, Mateus Itiro Tamazawskas Otake, Diego Di Felipe Ávila Alcantara, Rosilene Silva Lima, Ana Paula Borges de Souza, Janaina Silva da Costa Rodrigues, Margareth Maria Braun Guimarães Imbiriba, Rommel Mario Rodriguez Burbano

    Background: Solid neoplasms have a heterogeneous incidence worldwide and in Brazil. Thus, the region delimited by the Legal Amazon has a distinct epidemiological profile. In Pará, Ophir Loyola Cancer Hospital(OLCH) accounts for 71.11% of hospital visits in the state. Methods: This was an ecological, exploratory, and mixed descriptive studythat investigated the epidemiological profile of patients with cancer treated at OLCH from January to December 2020. Sociodemographic data at admission were the primary variables, which were analyzed according to spatial distribution. Results: In this study, the data of 2952 patients were analyzed, with the majority being between the ages of 50 and 79 years (62.47%), female (59.49%), and diagnosed but without previous treatment (87.30%). The most common cancers were breast (16.50%), cervical (13.40%), stomach (8.98%), and prostate (7.72%). Of the 12 integration regions, Guajará had the highest number of referrals (49.86%), followed by Guamá (12.94%) and Caeté River (8.98%). Conclusion: The profile of care at OLCH showed a high incidence of solid malignancies compared to that in other regions of Brazil, indicating environmental and sociocultural influences on the carcinogenic profile present in the eastern Amazon.